Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:2712-2716

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Du, X.-J.
Right arrow Articles by Dart, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du, X.-J.
Right arrow Articles by Dart, A. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antibiotics
*Cardiomyopathy
Hazardous Substances DB
*GENTAMYCIN
*PRAZOSIN HYDROCHLORIDE
*RESERPINE

(Circulation. 1995;91:2712-2716.)
© 1995 American Heart Association, Inc.


Articles

Suppression of Ventricular Arrhythmias During Ischemia-Reperfusion by Agents Inhibiting Ins(1,4,5)P3 Release

Xiao-Jun Du, MB, PhD; Karen E. Anderson, BSc; Alexander Jacobsen, BSc, MBBS; Elizabeth A. Woodcock, PhD; Anthony M. Dart, MRCP, PhD

From the Alfred and Baker Medical Unit and Cellular Biochemistry Laboratory, Alfred Hospital and Baker Medical Research Institute, Melbourne, Australia.

Correspondence to Dr Anthony Dart, Alfred and Baker Medical Unit, Baker Medical Research Institute, Commercial Rd, Prahran (Melbourne), Victoria 3181, Australia.

Background Reperfusion following myocardial ischemia causes a rapid and transient release of inositol (1,4,5)triphosphate [Ins(1,4,5)P3]. The aim of this study was to test whether this increased Ins(1,4,5)P3 release was important for the development of ventricular arrhythmias and whether agents that inhibit this signal transduction pathway, such as aminoglycoside antibiotics, suppress arrhythmias.

Methods and Results In perfused rat hearts, ventricular tachycardia (VT), ventricular fibrillation (VF), and accumulation of Ins(1,4,5)P3 were measured during early reperfusion. A number of different compounds, including neomycin, gentamicin, streptomycin, spermine, reserpine, and prazosin, were effective in inhibiting the reperfusion-induced Ins(1,4,5)P3 release and the onset of VT and VF in parallel. A strong correlation existed between Ins(1,4,5)P3 content, measured at 2 minutes of reperfusion, and the incidence of reperfusion VT and VF. In addition, intravenous gentamicin suppressed the onset of arrhythmias under ischemic and reperfusion conditions in vivo.

Conclusions Our results are consistent with the view that Ins(1,4,5)P3 release plays a pivotal role in mediating arrhythmias during early reperfusion. Agents inhibiting Ins(1,4,5)P3 release are antiarrhythmic and may have potential use clinically.


Key Words: arrhythmia • ischemia • reperfusion




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Wacker, L. M. Kosloski, W. J. R. Gilbert, C. D. Touchberry, D. S. Moore, J. K. Kelly, M. Brotto, and J. A. Orr
Inhibition of Thromboxane A2-Induced Arrhythmias and Intracellular Calcium Changes in Cardiac Myocytes by Blockade of the Inositol Trisphosphate Pathway
J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 917 - 924.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A. Woodcock, P. M. Kistler, and Y.-K. Ju
Phosphoinositide signalling and cardiac arrhythmias
Cardiovasc Res, May 1, 2009; 82(2): 286 - 295.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A. Woodcock, X.-J. Du, M. E. Reichelt, and R. M. Graham
Cardiac {alpha}1-adrenergic drive in pathological remodelling
Cardiovasc Res, February 1, 2008; 77(3): 452 - 462.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Lanzafame, L. Turnbull, F. Amiramahdi, J. F. Arthur, H. Huynh, and E. A. Woodcock
Inositol phospholipids localized to caveolae in rat heart are regulated by {alpha}1-adrenergic receptors and by ischemia-reperfusion
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2059 - H2065.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. Li, A. V. Zima, F. Sheikh, L. A. Blatter, and J. Chen
Endothelin-1-Induced Arrhythmogenic Ca2+ Signaling Is Abolished in Atrial Myocytes of Inositol-1,4,5-Trisphosphate(IP3)-Receptor Type 2-Deficient Mice
Circ. Res., June 24, 2005; 96(12): 1274 - 1281.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. P Headrick, L. Willems, K. J Ashton, K. Holmgren, J. Peart, and G P. Matherne
Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression
J. Physiol., June 15, 2003; 549(3): 823 - 833.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Woodcock, B. H. Wang, J. F. Arthur, A. Lennard, S. J. Matkovich, X.-J. Du, J. H. Brown, and R. D. Hannan
Inositol Polyphosphate 1-Phosphatase Is a Novel Antihypertrophic Factor
J. Biol. Chem., June 14, 2002; 277(25): 22734 - 22742.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. Mackenzie, M. D Bootman, M. Laine, M. J Berridge, J. Thuring, A. Holmes, W.-H. Li, and P. Lipp
The role of inositol 1,4,5-trisphosphate receptors in Ca2+ signalling and the generation of arrhythmias in rat atrial myocytes
J. Physiol., June 1, 2002; 541(2): 395 - 409.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev, April 1, 2001; 81(2): 767 - 806.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Duru, M. Barton, T. F. Luscher, and R. Candinas
Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?
Cardiovasc Res, February 1, 2001; 49(2): 272 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Matkovich and E. A. Woodcock
Ca2+-activated but Not G Protein-mediated Inositol Phosphate Responses in Rat Neonatal Cardiomyocytes Involve Inositol 1,4,5-Trisphosphate Generation
J. Biol. Chem., April 6, 2000; 275(15): 10845 - 10850.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Gysembergh, S. Lemaire, C. Piot, C. Sportouch, S. Richard, R. A. Kloner, and K. Przyklenk
Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2458 - H2469.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-J. Du and A. M. Dart
Role of sympathoadrenergic mechanisms in arrhythmogenesis
Cardiovasc Res, September 1, 1999; 43(4): 832 - 834.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Carmeliet
Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias
Physiol Rev, July 1, 1999; 79(3): 917 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Kurz, I. Schneider, R. Tolg, and G. Richardt
Alpha1-adrenergic receptor-mediated increase in the mass of phosphatidic acid and 1,2-diacylglycerol in ischemic rat heart
Cardiovasc Res, April 1, 1999; 42(1): 48 - 56.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Hatta, R. Maruyama, S. J. Marshall, M. Imamura, and R. Levi
Bradykinin Promotes Ischemic Norepinephrine Release in Guinea Pig and Human Hearts
J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 919 - 927.
[Abstract] [Full Text]


Home page
CirculationHome page
E. A. Woodcock, N. Reyes, A. N. Jacobsen, and X.-J. Du
Inhibition of Inositol(1,4,5)Trisphosphate Generation by Endothelin-1 During Postischemic Reperfusion : A Novel Antiarrhythmic Mechanism
Circulation, February 16, 1999; 99(6): 823 - 828.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. N. Harrison, D. J. Autelitano, B. H. Wang, C. Milano, X.-J. Du, and E. A. Woodcock
Reduced Reperfusion–Induced Ins(1,4,5)P3 Generation and Arrhythmias in Hearts Expressing Constitutively Active {alpha}1B-Adrenergic Receptors
Circ. Res., December 14, 1998; 83(12): 1232 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A Woodcock, S. J Matkovich, and O. Binah
Ins(1,4,5)P3 and cardiac dysfunction
Cardiovasc Res, November 1, 1998; 40(2): 251 - 256.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J Curtis
Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation
Cardiovasc Res, July 1, 1998; 39(1): 194 - 215.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. Felzen, M. Shilkrut, H. Less, I. Sarapov, G. Maor, R. Coleman, R. B. Robinson, G. Berke, and O. Binah
Fas (CD95/Apo-1)–Mediated Damage to Ventricular Myocytes Induced by Cytotoxic T Lymphocytes From Perforin-Deficient Mice : A Major Role for Inositol 1,4,5-Trisphosphate
Circ. Res., March 9, 1998; 82(4): 438 - 450.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Watanabe, T. Ishigami, Y. Kawano, T. Umahara, A. Nakamori, S. Mizushima, K. Hibi, I. Kobayashi, K. Tamura, H. Ochiai, et al.
Angiotensin-Converting Enzyme Gene I/D Polymorphism and Carotid Plaques in Japanese
Hypertension, September 1, 1997; 30(3): 569 - 573.
[Abstract] [Full Text]


Home page
CirculationHome page
A. N. Jacobsen, X.-J. Du, K. A. Lambert, A. M. Dart, and E. A. Woodcock
Arrhythmogenic Action of Thrombin During Myocardial Reperfusion via Release of Inositol 1,4,5-Triphosphate
Circulation, January 1, 1996; 93(1): 23 - 26.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. F. Arthur, S. J. Matkovich, C. J. Mitchell, T. J. Biden, and E. A. Woodcock
Evidence for Selective Coupling of alpha 1-Adrenergic Receptors to Phospholipase C-beta 1 in Rat Neonatal Cardiomyocytes
J. Biol. Chem., September 28, 2001; 276(40): 37341 - 37346.
[Abstract] [Full Text] [PDF]